Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Search for other papers by Vitalii Ulychnyi in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
Search for other papers by Anna Popławska-Kita in
Google Scholar
PubMed
Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed
Search for other papers by Marcin Adamski in
Google Scholar
PubMed
Search for other papers by Angelika Buczyńska in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland
Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed
.8 0.35 T2DM (%) 23 41 <0.01 Hyperlipidaemia (%) 72.4 53.6 0.01 Obesity (%) 34.7 33.9 0.9 CKD (%) 28.5 32.1 0.7 Stroke (%) 2.9 1.8 0.6 STEMI (%) 5 5.4 0.6 NSTEMI (%) 0
Search for other papers by Marta Fichna in
Google Scholar
PubMed
Search for other papers by Piotr P Małecki in
Google Scholar
PubMed
Search for other papers by Magdalena Żurawek in
Google Scholar
PubMed
Search for other papers by Katarzyna Furman in
Google Scholar
PubMed
Search for other papers by Bolesław Gębarski in
Google Scholar
PubMed
Search for other papers by Piotr Fichna in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
Gamberini M Correia MR Ruiz MO Mangueira CL Matioli SR Vasconcelos DM & Silva ME . The PTPN22 1858T allele but not variants in the proximal promoter region of IL-21 gene is associated with the susceptibility to type 1 diabetes and the
Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España
Search for other papers by Jorge Gabriel Ruiz-Sánchez in
Google Scholar
PubMed
Servicio de Endocrinología y Nutrición. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, España
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, España
Search for other papers by Alfonso Luis Calle-Pascual in
Google Scholar
PubMed
Servicio de Endocrinología y Nutrición. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, España
Search for other papers by Miguel Ángel Rubio-Herrera in
Google Scholar
PubMed
Servicio de Endocrinología y Nutrición. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, España
Search for other papers by María Paz De Miguel Novoa in
Google Scholar
PubMed
Search for other papers by Emilia Gómez-Hoyos in
Google Scholar
PubMed
Servicio de Endocrinología y Nutrición. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, España
Search for other papers by Isabelle Runkle in
Google Scholar
PubMed
.7) 61 (76.3) 19 (23.8) <0.001 a Comorbidities Hypertension, n (%) 85 (75.9) 22 (68.8) 63 (78.8) 0.264 Low-sodium diet, n (%) 53 (47.3) 17 (53.1) 36 (45) 0.437 DM, n (%) >10 years 59 (52.7) 35 (31
Search for other papers by Emily Warmington in
Google Scholar
PubMed
Search for other papers by Gabrielle Smith in
Google Scholar
PubMed
Search for other papers by Vasileios Chortis in
Google Scholar
PubMed
Department of Neurosurgery, Technical University Munich (TMU), Munich, Germany
Search for other papers by Raimunde Liang in
Google Scholar
PubMed
Search for other papers by Juliane Lippert in
Google Scholar
PubMed
Search for other papers by Sonja Steinhauer in
Google Scholar
PubMed
Search for other papers by Laura-Sophie Landwehr in
Google Scholar
PubMed
Medizinische Klinik Und Poliklinik III, University Hospital Carl Gustav Carus, Dresden, Germany
Search for other papers by Constanze Hantel in
Google Scholar
PubMed
Search for other papers by Katja Kiseljak-Vassiliades in
Google Scholar
PubMed
Search for other papers by Margaret E Wierman in
Google Scholar
PubMed
Search for other papers by Barbara Altieri in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Paul A Foster in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Cristina L Ronchi in
Google Scholar
PubMed
Skaria and Sana Khan for partial contribution to the initial establishment of the cell culture experiments. References 1 Else T Kim AC Sabolch A Raymond VM Kandathil A Caoili EM Jolly S Miller BS Giordano TJ & Hammer GD
Search for other papers by Natacha Driessens in
Google Scholar
PubMed
Search for other papers by Madhu Prasai in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Christophe De Block in
Google Scholar
PubMed
Search for other papers by Eva Van Caenegem in
Google Scholar
PubMed
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Search for other papers by Frank Nobels in
Google Scholar
PubMed
Search for other papers by Christophe Ghys in
Google Scholar
PubMed
Search for other papers by Laurent Vroonen in
Google Scholar
PubMed
Search for other papers by Corinne Jonas in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
-morbidities recorded: hypertension, T2DM and osteoporosis mg, milligram; No, number; PAI, primary adrenal insufficiency; SAI, secondary adrenal insufficiency; T2DM, type 2 diabetes mellitus; TB, tuberculosis. We performed a Belgian survey of PAI
Search for other papers by Debra M Gordon in
Google Scholar
PubMed
Search for other papers by Pablo Beckers in
Google Scholar
PubMed
Search for other papers by Emilie Castermans in
Google Scholar
PubMed
Search for other papers by Sebastian J C M M Neggers in
Google Scholar
PubMed
Search for other papers by Liliya Rostomyan in
Google Scholar
PubMed
Search for other papers by Vincent Bours in
Google Scholar
PubMed
Search for other papers by Patrick Petrossians in
Google Scholar
PubMed
Search for other papers by Vinciane Dideberg in
Google Scholar
PubMed
Search for other papers by Albert Beckers in
Google Scholar
PubMed
Search for other papers by Adrian F Daly in
Google Scholar
PubMed
. SDHB c.287G>A p.Gly96Asp Pituitary P04 F 28 Pituitary macroadenoma (prolactinoma), resistant to dopamine agonists; neurosurgery (×2) None MEN1 c.1618C>T p.Pro540Ser P21 M 25 Acromegaly (macroadenoma
Division of Endocrinology and Metabolism, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Search for other papers by Supitcha Patjamontri in
Google Scholar
PubMed
NIHR Health Protection Research Unit on Chemical Radiation Threats and Hazards, Imperial College London, London, UK
Search for other papers by Alexander Spiers in
Google Scholar
PubMed
NIHR Health Protection Research Unit on Chemical Radiation Threats and Hazards, Imperial College London, London, UK
National Institute for Health Research (NIHR) Health Protection Research Unit in Environmental Exposures and Health, Imperial College London, London, UK
Mohn Centre for Children’s Health and Wellbeing, Imperial College London, London, UK
Search for other papers by Rachel B Smith in
Google Scholar
PubMed
NIHR Health Protection Research Unit on Chemical Radiation Threats and Hazards, Imperial College London, London, UK
Search for other papers by Chen Shen in
Google Scholar
PubMed
Search for other papers by Jo Adaway in
Google Scholar
PubMed
Search for other papers by Brian G Keevil in
Google Scholar
PubMed
NIHR Health Protection Research Unit on Chemical Radiation Threats and Hazards, Imperial College London, London, UK
National Institute for Health Research (NIHR) Health Protection Research Unit in Environmental Exposures and Health, Imperial College London, London, UK
Mohn Centre for Children’s Health and Wellbeing, Imperial College London, London, UK
Search for other papers by Mireille B Toledano in
Google Scholar
PubMed
Search for other papers by S Faisal Ahmed in
Google Scholar
PubMed
steroids in the present study, a total of 925 boys and 620 girls had at least one saliva sample analysed at one of two time points, T1 (between March 2015 and July 2016) and T2 (between February 2017 and July 2018). Figure 1 shows the cohort data relevant
Search for other papers by Paola Parra Ramírez in
Google Scholar
PubMed
Search for other papers by Patricia Martín Rojas-Marcos in
Google Scholar
PubMed
Medicine Department, Basque Country University, Bilbao, Spain
Search for other papers by Miguel Paja Fano in
Google Scholar
PubMed
Search for other papers by Marga González Boillos in
Google Scholar
PubMed
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain
Search for other papers by Eider Pascual-Corrales in
Google Scholar
PubMed
Search for other papers by Ana García-Cano in
Google Scholar
PubMed
Search for other papers by Jorge Gabriel Ruiz-Sanchez in
Google Scholar
PubMed
Search for other papers by Almudena Vicente in
Google Scholar
PubMed
Search for other papers by Emilia Gómez-Hoyos in
Google Scholar
PubMed
Search for other papers by Rui Ferreira in
Google Scholar
PubMed
Search for other papers by Iñigo García Sanz in
Google Scholar
PubMed
Search for other papers by Mònica Recasens in
Google Scholar
PubMed
Search for other papers by Begoña Pla Peris in
Google Scholar
PubMed
Search for other papers by Rebeca Barahona San Millan in
Google Scholar
PubMed
CIBEROBN, Madrid, Spain
Search for other papers by María José Picón César in
Google Scholar
PubMed
Search for other papers by Patricia Díaz Guardiola in
Google Scholar
PubMed
Search for other papers by Juan Jesús García González in
Google Scholar
PubMed
Search for other papers by Carolina Perdomo in
Google Scholar
PubMed
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
Search for other papers by Laura Manjón in
Google Scholar
PubMed
Search for other papers by Rogelio García-Centeno in
Google Scholar
PubMed
Search for other papers by Juan Carlos Percovich in
Google Scholar
PubMed
Search for other papers by Ángel Rebollo Román in
Google Scholar
PubMed
Search for other papers by Paola Gracia Gimeno in
Google Scholar
PubMed
Search for other papers by Cristina Robles Lázaro in
Google Scholar
PubMed
Search for other papers by Manuel Morales in
Google Scholar
PubMed
Search for other papers by Felicia Hanzu in
Google Scholar
PubMed
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain
University of Alcalá, Madrid, Spain
Search for other papers by Marta Araujo-Castro in
Google Scholar
PubMed
Guideline in collaboration with the European Network for the Study of Adrenal Tumors . European Journal of Endocrinology 2016 175 G1 – G34 . ( https://doi.org/10.1530/EJE-16-0467 ) 25 Lloyd-Jones DM Evans JC Levy D . Hypertension in adults across
Search for other papers by Irena Kasacka in
Google Scholar
PubMed
Search for other papers by Żaneta Piotrowska in
Google Scholar
PubMed
Search for other papers by Natalia Domian in
Google Scholar
PubMed
Search for other papers by Alicja Lewandowska in
Google Scholar
PubMed
.1210/en.2017-03061 ) 7 Kim AC Reuter AL Zubair M Else T Serecky K Bingham NC Lavery GG Parker KL Hammer GD . Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex
Search for other papers by Magdalena Lech in
Google Scholar
PubMed
Search for other papers by Ruvini Ranasinghe in
Google Scholar
PubMed
Faculty of Life Sciences and Medicine, School of Life Course Sciences, King’s College London, London, UK
Search for other papers by Royce P Vincent in
Google Scholar
PubMed
Search for other papers by David R Taylor in
Google Scholar
PubMed
Search for other papers by Lea Ghataore in
Google Scholar
PubMed
Search for other papers by James Luxton in
Google Scholar
PubMed
Quebec Heart and Lung Institute, Laval University, Quebec, Canada
Search for other papers by Fannie Lajeunesse-Trempe in
Google Scholar
PubMed
Search for other papers by Pia Roser in
Google Scholar
PubMed
Search for other papers by Eftychia E Drakou in
Google Scholar
PubMed
Search for other papers by Ling Ling Chuah in
Google Scholar
PubMed
Barts and the London School of Medicine, Centre for Endocrinology, William Harvey Institute, London, UK
Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Search for other papers by Simon J B Aylwin in
Google Scholar
PubMed
Obesity, Type 2 Diabetes and Immunometabolism Research Group, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Course Sciences, King’s College London, London, UK
Division of Reproductive Health, Warwick Medical School, University of Warwick, Coventry, UK
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
mass ( n = 25) or pregnant women undergoing endocrine assessment ( n = 10) in the period between April 2019 and June 2020 were included in the analysis ( Table 1 ). Serum cortisol, full thyroid function tests (TSH, free T4 and free T3